Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
ParaTechs
AddedFeb 18, 2024
UpdatedJun 18, 2026
ParaTechs

ParaTechs

US-based ParaTechs develops innovative biotech products and technologies, fostering discovery and development through partnerships and licensing.

HQ
Lexington, KY, US
Founded
2004
Overview
Compare
Fundraising
Employees
Website

ParaTechs, founded in 2004 and based on intellectual property from the University of Kentucky, aims to develop innovative biotechnologies that advance discovery and development in the biotech sector. The company offers a range of products, including the Cervical Manipulation Rod, mNSET Device, and mC&I Device, which facilitate non-surgical embryo transfer and artificial insemination in rodents. ParaTechs focuses on commercial licensing and collaborative research to bring its novel products to market.

ParaTechs has made significant strides in biotechnology, particularly in rodent-assisted reproduction. Their devices, such as the NSET and C&I, have been featured in publications like JoVE, highlighting their impact on reducing the need for invasive procedures in laboratory settings. These innovations contribute to more humane and efficient research practices, underscoring ParaTechs' role in advancing biotech solutions.

ParaTechs - Similar Companies

ParaGen Technologies logo

ParaGen Technologies

ReproHealth Technologies logo

ReproHealth Technologies

PartTec logo

PartTec

Paratus Diagnostics logo

Paratus Diagnostics

SenesTech logo

SenesTech

senestech.com

Parimer Scientific logo

Parimer Scientific

parimer.com

Phoenix S&T logo

Phoenix S&T

phoenix-st.com

Parion Sciences logo

Parion Sciences

parion.com

Jointechlabs logo

Jointechlabs

jointechlabs.com

Paratus Sciences logo

Paratus Sciences

Reproductive Research Technologies logo

Reproductive Research Technologies

Reproductive Solutions logo

Reproductive Solutions

OpenCell Technologies logo

OpenCell Technologies

Proteotech logo

Proteotech

Benchtop Bioreactors logo

Benchtop Bioreactors

ParaTechs - Quick Facts

Who are ParaTechs' competitors?

Companies similar to ParaTechs include ParaGen Technologies, ReproHealth Technologies, PartTec and Paratus Diagnostics.

When was ParaTechs founded?

ParaTechs was founded in 2004.

Where is ParaTechs' headquarters located?

ParaTechs' headquarters is located in Lexington, KY, US.

When was ParaTechs' last funding round?

ParaTechs' most recent funding round was for $150k (USD) in May 2014.

How much has ParaTechs raised to-date?

As of May 27, 2014, ParaTechs has raised a total of $150k (USD).

How many employees does ParaTechs have?

ParaTechs has 4 employees as of Feb 4, 2024.

ParaTechs - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Licensing
  • Recurring
  • Transactional
Customer
  • Enterprise
Main Product
  • Biotech Products
Tags
  • Life Sciences
  • Research
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified